| 4.05 Data as of May 23 |  +0.09 / +2.27%Today’s Change | 2.60 Today|||52-Week Range 5.58 | +6.30% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $511.0M |
Antares Pharma, Inc. 100 Princeton South Ewing New Jersey 08628 |
| Other institutional | 24.86% |
| Mutual fund holders | 12.00% |
| Individual stakeholders | 11.40% |
| Paul K. Wotton, PhD, MBA | President, Chief Executive Officer & Director |
| Robert F. Apple, CPA | Chief Financial Officer, Secretary, & Executive VP |
| Jonathan S. Jaffe, MD | Vice President-Clinical Development |
| Peter L. Sadowski, PhD | Chief Technology Officer & Senior Vice President |
| Patrick Madsen | Vice President & GM-Parenteral Products Division |
.
